CymitQuimica logo

ACT-709478

CAS:

Ref. 3D-NYC65158

10mg
617.00€
25mg
1,034.00€
50mg
1,653.00€
100mg
2,577.00€
ACT-709478
Biosynth

Product Information

Name:ACT-709478
Brand:Biosynth
Description:ACT-709478 is an orally bioavailable, non-peptide small molecule for the treatment of epileptic patients. It has a pharmacokinetic half-life of about 4 hours and penetrates the blood–brain barrier. ACT-709478 has been shown to be effective in animal models of cardiovascular diseases. The drug is metabolized by cytochrome P450 enzymes and has functional groups that are not well characterized. The terminal half-life of this molecule is about 2 hours.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:425.4 g/mol
Formula:C22H18F3N5O
Purity:Min. 95%

Technical inquiry about: ACT-709478

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.